Zhejiang Jiuzhou Pharm Co Ltd (603456.SS) stock: key figures, P/E, revenue and dividend

Health Care · Pharmaceuticals · China · ISIN CNE100001W36

Price
16.58 CNY
Market cap
14.75 bn CNY
P/E (2025)
20.20
P/S (2025)
2.68
Dividend yield
1.21 %
Net margin
13.25 %
Return on equity (ROE)
8.37 %
Return on assets (ROA)
6.89 %

Zhejiang Jiuzhou Pharm Co Ltd financials

Fiscal year20242025
Revenue5.16 bn CNY5.51 bn CNY
Gross profit1.59 bn CNY2.03 bn CNY
Operating income732.19 m CNY1.23 bn CNY
EBIT715.31 m CNY929.58 m CNY
Net income606.10 m CNY730.07 m CNY
Diluted EPS – continuing operations0.67 CNY0.82 CNY

Full history since 2008, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Zhejiang Jiuzhou Pharm Co Ltd

Zhejiang Jiuzhou Pharmaceutical Co., Ltd operates as contract development and manufacturing organization (CDMO) company in China and internationally. The company offers small molecules, drug products, and peptide CDMO services. It also involved in business related to supporting the development of new drugs and pharmaceuticals. It serves global pharmaceutical companies, biotechnology companies, and scientific research institutions. Zhejiang Jiuzhou Pharmaceutical Co., Ltd was founded in 1973 and is headquartered in Taizhou, China.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 05.11.2026. Details in the risk notice.